SEER
HealthcareSeer, Inc.
$1.84
+$0.02 (+1.10%)
Jan 5, 2026
Price History (1Y)
Analysis
Seer, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $103.50M and 134 employees. The company operates within the biotechnology industry. Financially, Seer, Inc. reported revenue of $16.38M in its most recent quarter, with net income standing at -$79,348,000. The company's operating margin was -469.4%, while its profit margin was 0.0%. Additionally, the firm's return on equity (ROE) and return on assets (ROA) were -25.7% and -15.2%, respectively. In terms of liquidity, Seer, Inc. has a current ratio of 14.25 and a debt-to-equity ratio of 8.92, with $199.24M in cash and $24.25M in debt. Seer, Inc.'s valuation metrics include a price to sales ratio of 6.32 and an EV/EBITDA ratio of 0.94. The company's forward P/E is -1.35, while its gross margin was 50.7%. Notably, Seer, Inc. has a revenue growth rate of 2.2% year-over-year, but earnings growth is not available for comparison.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Seer, Inc.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Visit website →Key Statistics
- Market Cap
- $103.50M
- P/E Ratio
- N/A
- 52-Week High
- $2.49
- 52-Week Low
- $1.62
- Avg Volume
- 147.90K
- Beta
- 1.60
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 134